Publications by authors named "Maheera A Cheema"
Intravitreal bevacizumab as a primary treatment for idiopathic choroidal neovascularization.
Middle East Afr J Ophthalmol
July 2011
Purpose: To report long-term outcomes of the use of intravitreal bevacizumab in subjects with idiopathic choroidal neovascularization (ICNV).
Materials And Methods: Six consecutive subjects with ICNV were included in this prospective study. All subjects received 1.
Purpose: The purpose of this study was to evaluate the role of bevacizumab (Avastin), an antivascular endothelial growth factor agent, injected at the end of surgery for preventing postoperative recurrent vitreous hemorrhage in patients undergoing vitrectomy for diabetic eye disease.
Methods: This was a retrospective, comparative, and nonrandomized study on a consecutive series of patients who underwent vitrectomy for diabetic eye disease. Recurrence of postoperative vitreous hemorrhage was compared in patients with and without intravitreal 1.
Aim: To evaluate whether residual vitreous cortex removal has a role in the prevention of postoperative vitreous hemorrhage in diabetic vitrectomy.
Methods: Retrospective, comparative, nonrandomized study on a consecutive series of patients who underwent vitrectomy for diabetic eye disease. Recurrence of postoperative vitreous hemorrhage was compared in patients following surgery with and without residual vitreous cortex removal.
Purpose: To evaluate the role of intravitreal bevacizumab, an anti-vascular endothelial growth factor agent, injected at the time of cataract surgery on the postoperative progression of diabetic retinopathy (DR) and diabetic maculopathy.
Setting: Tertiary-care eye specialty hospital, Dhahran, Kingdom of Saudi Arabia.
Methods: Patients were randomized to a standardized procedure of phacoemulsification with intraocular lens implantation alone (control group) or to receive 1.